C35 overexpression defines subsets of human breast cancer and its immunoreceptor tyrosine-based activation motif represents a novel treatment target

E Katz; D Faratian; JMS Bartlett; K MacLeod; H Pedersen; A Larionov; EM Smith; AP Howell; JM Dixon; EE Evans; SP Langdon; DJ Harrison

首页> 外文期刊>Breast Cancer Research >C35 overexpression defines subsets of human breast cancer and its immunoreceptor tyrosine-based activation motif represents a novel treatment target

【24h】

C35 overexpression defines subsets of human breast cancer and its immunoreceptor tyrosine-based activation motif represents a novel treatment target

机译：C35过表达定义了人类乳腺癌的子集，其基于免疫受体酪氨酸的活化基序代表了一种新型治疗靶点

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Breast Cancer Research》 |2008年第2期|共页
作者
E Katz; D Faratian; JMS Bartlett; K MacLeod; H Pedersen; A Larionov; EM Smith; AP Howell; JM Dixon; EE Evans; SP Langdon; DJ Harrison;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类泌尿生殖器肿瘤;
关键词

相似文献

外文文献
中文文献
专利

1. Microglial activatory (immunoreceptor tyrosine-based activation motif)- and inhibitory (immunoreceptor tyrosine-based inhibition motif)-signaling receptors for recognition of the neuronal glycocalyx [J] . Linnartz B., Neumann H. Glia . 2013,第1期

机译：小胶质细胞激活（基于免疫受体酪氨酸的激活基序）和抑制（基于免疫受体酪氨酸的抑制基序）信号转导受体，用于识别神经元糖萼
2. Targeting Glycoprotein VI and the Immunoreceptor Tyrosine-Based Activation Motif Signaling Pathway (vol 34, pg 1615, 2014) [J] . Stegner D., Haining E. J., Nieswandt B. Arteriosclerosis, thrombosis, and vascular biology . 2015,第4期

机译：靶向糖蛋白VI和基于酪氨酸的免疫受体激活基序信号通路（第34卷，第1615页，2014年）
3. Targeting glycoprotein vi and the immunoreceptor tyrosine-based activation motif signaling pathway [J] . StegnerD., HainingE.J., NieswandtB. Arteriosclerosis, thrombosis, and vascular biology . 2014,第8期

机译：靶向糖蛋白vi和基于免疫受体酪氨酸的激活基序信号通路
4. Acoustically Activated Accumulation and Release from Estrone-Targeted Liposomes in the Treatment of Breast Cancer [C] . Najla M. Salkho, Rute F. Vitor, Ana M. Martins, Society for Biomaterials annual meeting and exposition . 2018

机译：耳蜗靶向脂质体的声激活积聚和释放在乳腺癌的治疗中。
5. Biophysical studies of the allosteric regulatory mechanism of Syk tandem SH2 domains interacting with immunoreceptor tyrosine-based activation motifs [D] . Feng, Chao. 2016

机译：Syk串联SH2域与基于免疫受体酪氨酸的激活基序相互作用的变构调节机制的生物物理研究。
6. C35 overexpression defines subsets of human breast cancer and its immunoreceptor tyrosine-based activation motif represents a novel treatment target [O] . E Katz, D Faratian, JMS Bartlett, 2008

机译：C35过表达定义了人类乳腺癌的子集其基于免疫受体酪氨酸的活化基序代表了一种新型治疗靶点
7. C35 overexpression defines subsets of human breast cancer and its immunoreceptor tyrosine-based activation motif represents a novel treatment target [O] . Katz, E., Faratian, D., Bartlett, J. M. S., 2008

机译：C35过表达定义了人类乳腺癌的子集，其基于免疫受体酪氨酸的活化基序代表了一种新型治疗靶点
8. Targeting MED1 LxxLL Motifs for Tissue-Selective Treatment of Human Breast Cancer. [R] . Zhang, X. 2014

机译：针对mED1 LxxLL图案进行组织选择性治疗人乳腺癌。

C35 overexpression defines subsets of human breast cancer and its immunoreceptor tyrosine-based activation motif represents a novel treatment target

著录项

引文网络

相似文献

相关主题

期刊订阅